Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management

scientific article

Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBMT.2014.04.010
P932PMC publication ID4163090
P698PubMed publication ID24747335
P5875ResearchGate publication ID261766267

P50authorBrian D. GonzalezQ42758518
Anna BarataQ86760391
Laura J. JohnstonQ116194191
P2093author name stringOxana Palesh
Shelli Kesler
Heather S L Jim
Joseph Pidala
Kristin M Phillips
Jiyeon M Jeong
Bryan Evans
Ashley M Nelson
P2860cites workClinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adultsQ24643584
Small B cell lymphocytic lymphoma presenting as obstructive sleep apneaQ24798533
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness ScaleQ28256570
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchQ29547257
Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation.Q33183929
The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).Q33914006
Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatmentQ34228792
Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host diseaseQ34427665
Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantationQ34729742
Clinical guideline for the evaluation and management of chronic insomnia in adults.Q34852294
Sleep measured by polysomnography in patients receiving high-dose chemotherapy for multiple myeloma prior to stem cell transplantationQ35072925
Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized studyQ36382493
Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancerQ36671163
Lagged relationships among sleep disturbance, fatigue, and depressed mood during chemotherapy.Q36979833
Exercise in patients receiving hematopoietic stem cell transplantation: lessons learned and results from a feasibility studyQ37039818
Quality of life concerns and depression among hematopoietic stem cell transplant survivorsQ37141324
Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.Q37334978
Sleep aid prescribing practices during neoadjuvant or adjuvant chemotherapy for breast cancerQ37851137
Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30.Q37878252
Preliminary prospective explanatory observation on the impact of 3-month steroid therapy on the objective measures of sleep-disordered breathingQ39729013
Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndromeQ40552467
Monitoring vital signs in a bone marrow transplant unit: are they needed in the middle of the night?Q40596827
Association of busulfan and cyclophosphamide conditioning with sleep disorders after hematopoietic stem cell transplantation.Q42879093
Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantationQ44021078
2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disordersQ44675985
Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differencesQ44763689
Zolpidem is independently associated with increased risk of inpatient fallsQ46052999
Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation settingQ46878050
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controlsQ47577769
The long-term psychosocial effects of haematopoetic stem cell transplantationQ47688304
Quality of life immediately after peripheral blood stem cell transplantationQ47729481
Multimodal exercise training during myeloablative chemotherapy: a prospective randomized pilot trialQ48179256
Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of lifeQ48186768
???Q27024854
Effects of exercise on fatigue, sleep, and performance: a randomized trial.Q48224998
Development and validation of a subjective post sleep diary (SPSD) to assess sleep status in subjects with restless legs syndromeQ48294265
Sleep disturbance in hospitalized recipients of stem cell transplantationQ48300454
Bone marrow and peripheral white blood cells number is affected by sleep deprivation in a murine experimental modelQ48310749
Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep DisQ48324219
Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapyQ48368641
Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month periodQ48388898
Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantationQ48412506
Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007.Q48468125
Symptom burden in patients undergoing autologous stem-cell transplantationQ48471674
Social support and quality of life of patients prior to stem cell or bone marrow transplantation.Q48494476
Fatigue and physical activity in patients undergoing hematopoietic stem cell transplantQ48502178
Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effectsQ48536988
Empirical validation of the Insomnia Severity Index in cancer patientsQ48580617
Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patientsQ48592626
Quality of life after stem cell transplantation: a patient, partner and physician perspectiveQ48670596
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell supportQ48673800
Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise interventionQ48678395
A prospective evaluation of patients' health-related quality of life during auto-SCT: a 3-year follow-upQ48743489
The Pittsburgh Sleep DiaryQ48840728
A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantationQ49129952
A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantationQ49286631
Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.Q51933938
Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls.Q51988742
Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation.Q52551121
A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT.Q53114133
Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia.Q53147155
Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument.Q53185260
Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls.Q53304627
Quality of life in patients randomized to receive a bone marrow or a peripheral blood allograft.Q53305813
Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.Q53346464
Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantationQ58376056
A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phaseQ59620696
Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantationQ78020367
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantationQ78449580
NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adultsQ79795154
Pregabalin in restless legs syndrome with and without neuropathic painQ80298311
Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective studyQ80538896
Quality of life and social integration after allogeneic hematopoietic SCTQ81798720
Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantationQ83171044
P433issue10
P304page(s)1465-1484
P577publication date2014-04-18
P1433published inBiology of Blood and Marrow TransplantationQ15754328
P1476titleSleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management
P478volume20

Reverse relations

cites work (P2860)
Q60713770Cancer survivors in the workplace: sleep disturbance mediates the impact of cancer on healthcare expenditures and work absenteeism
Q42324641Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue
Q47868494Coping, stress, and insomnia in hematopoietic stem cell transplant candidates.
Q47673326Efficacy and Safety of the Traditional Herbal Medicine, Gamiguibi-tang, in Patients With Cancer-Related Sleep Disturbance: A Prospective, Randomized, Wait-List-Controlled, Pilot Study
Q30854718Emerging uses of patient generated health data in clinical research
Q36766324National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report
Q38808511National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.
Q50173239Palliative care during and following allogeneic hematopoietic stem cell transplantation
Q90004112Patients' quality of life: Validation of the functional assessment of cancer therapy-bone marrow transplant (FACT-BMT) instrument for the Mexican population
Q90185358Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes
Q87995382Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation
Q52689260Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial.
Q47263498Sleep disruption among cancer patients following autologous hematopoietic cell transplantation.
Q37634083The Quest for Mindful Sleep: A Critical Synthesis of the Impact of Mindfulness-Based Interventions for Insomnia
Q30964688The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology

Search more.